News

XBI surged 80% in one year but endured a 54% drawdown, while IXJ delivered steadier gains with half volatility and a 1.4% dividend.

Sunrun’s latest internal fair value estimate has shifted from US$18.84 to US$17.05, signaling a more conservative stance on the stock’s pricing. This reset lines up with recent Street research that balances enthusiasm for Sunrun’s grid scale storage and AI related projects with concerns about execution, cash generation, and sector level risks. As you read on, you will see how these moving pieces shape the evolving Sunrun narrative and what that can mean for your own view on the stock. Stay...

Earnings, Dividend and Buyback Put Hilton Worldwide Holdings in Focus Hilton Worldwide Holdings (HLT) has drawn investor attention after reporting second quarter 2026 results, reaffirming its regular cash dividend and updating progress on a long running share repurchase program. For the second quarter ended June 30, 2026, Hilton Worldwide Holdings reported revenue of US$3,341 million compared with US$3,137 million a year earlier. Net income was US$482 million, with basic earnings per share...

Halozyme earnings beat and guidance hike reshape the story Halozyme Therapeutics (HALO) just put fresh numbers on the table, reporting second quarter 2026 results, raising full year revenue guidance and updating progress on its share repurchase programs. For the quarter ended June 30, 2026, revenue was reported at US$481 million compared with US$325.72 million for the same period a year earlier. Net income for the quarter was US$229.91 million compared with US$165.16 million a year ago. Basic...

MARA Holdings (NasdaqCM:MARA) announced major boardroom changes as it pushes further into AI focused infrastructure and away from a pure bitcoin mining profile. Two directors resigned and were immediately replaced by industry figures with backgrounds in power and hyperscale data centers to support the company’s new direction. The board reshuffle came alongside the release of quarterly results that showed a substantial net loss and plans to expand power availability and AI capacity. These...

Abbott Laboratories buyback update Abbott Laboratories (ABT) has completed a share repurchase tranche that saw the company buy back 14,015,097 shares for about US$1.35b, including 11,599,094 shares between April and June 2026. See our latest analysis for Abbott Laboratories. Abbott Laboratories shares trade at US$107.81 and have gained 27.86% over the past 90 days, while the year-to-date share price return is down 13.19% and the 1-year total shareholder return is down 17.86%. This points to...

Pinterest stock looks like a bargain following its latest post-earnings sell-off.

Cheniere Energy (NYSE:LNG) raised its 2026 financial outlook for a second consecutive quarter, citing higher production, stronger marketing margins and optimization activity as global LNG markets faced supply disruption tied to constrained flows through the Strait of Hormuz. The company reported se

Eli Lilly and Company (NYSE:LLY) reported 48% revenue growth in the second quarter of 2026, driven primarily by continued demand for its cardiometabolic medicines MOUNJARO and ZEPBOUND, while raising its full-year revenue and earnings guidance. Chair and CEO Dave Ricks said the company delivered gr

Centrus Energy (NYSE:LEU) reported second-quarter 2026 revenue growth and expanded its commercial backlog as the company advanced plans to build U.S. uranium-enrichment capacity for low-enriched uranium, or LEU, and high-assay low-enriched uranium, or HALEU. Revenue for the quarter ended June 30 ro

Consumer sentiment is flashing recession warnings, yet three blue-chip dividend legends are quietly building cases for returns that would shock most defensive investors heading into 2027.

Billings' non-discretionary sale reduced his direct holdings by 17% to cover vested restricted stock unit obligations, while he maintains 56,094 shares worth $1.3 million.

XLV's concentrated 60-stock portfolio beat VHT's broader 423 holdings over five years, though VHT delivered stronger 1-year returns.

Alphabet's growth opportunities look like an embarrassment of riches.

Aug. 12 is a big date for investors interested in Nebius.

JPMorgan Chase & Co. CEO Jamie Dimon warned that high leverage across financial markets could magnify disruptions, urging investors to be aware of hidden borrowing risks. On Wednesday, in an interview with CNBC’s Leslie Picker, Dimon said, "Margin debt is...

Tech giants are pouring hundreds of billions into AI while quietly gutting the workforces that built them, and the labor data reveals a layoff rate that dwarfs anything seen during the 2008 financial crisis or the dot-com bust.

JPMorgan Chase is predicting that gold prices are heading higher; how can you play that prediction?

More than a year after announcing plans to phase it out, Google is finally moving ahead with a major change that will affect millions of consumers. The familiar tool has been part of people's daily routines for years, helping with everything from simple questions and reminders to controlling ...

Palantir's blockbuster Q2 results has Wall Street divided with valuation fears and growth bulls tussling.

One generates 20% net margins on $12.2B in revenue; the other pulls $10.8B in free cash flow despite a 1.7x debt load.

Ripple just launched a major new banking product -- and XRP is barely part of the story.

ChatGPT went from generating roughly $10 million a month on Apple's App Store in Jan. 2024 to more than $275 million in July 2026. Apple did not build ChatGPT. It does not train it, run it, or market it. But every time someone subscribes, Apple collects a commission. That dynamic is playing out ...

SanDisk delivered record earnings, but investors remain focused on whether the memory boom can last.

AMD beat top and bottom lines, raised guidance, and still got punished. Does the pullback create an attractive entry point for investors?

American Express (AXP) has drawn fresh attention after completing a US$1.6b fixed income offering of preferred depository shares, giving investors another lens on the company alongside its common stock performance and recent earnings commentary. See our latest analysis for American Express. Against this backdrop, American Express shares trade at US$340.91, with a 90 day share price return of 7.87% even as the year to date share price return is down 8.54%. The 5 year total shareholder return...

DaVita stock has climbed 69.6% over the past three years. After a recent pullback and a strong value score, the current price still raises questions about how much upside investors are actually paying for. Over the past 3 years, DaVita has returned 69.6%, which puts recent share price weakness in the context of a longer period of strong gains. Support for the valuation can come from expectations that DaVita benefits from growing demand for integrated kidney and metabolic care. Execution...

In early August 2026, Niagen Bioscience Inc. reported slightly lower quarterly sales and net income year on year, while also expanding access to its Tru Niagen® healthy‑aging NAD+ supplement via Walmart.com, initially offering 300 mg bottles in 30‑ and 90‑count formats. A new peer‑reviewed analysis in Aging Cell linked Niagen’s nicotinamide riboside supplementation to reduced muscle epigenetic age acceleration, adding scientific depth to its healthy‑aging positioning just as distribution...

Circle Internet Group (CRCL) just posted its second quarter 2026 results, shifting from a large loss a year ago to a profit, while also updating investors on progress with its Arc blockchain platform. See our latest analysis for Circle Internet Group. Circle Internet Group’s recent earnings swing to profit, Arc progress updates and regulatory milestones have come alongside a 1 day share price return of 5.36% and a 7 day share price return of 6.48%. However, the 1 year total shareholder return...

Supply may catch up to demand, but it won't happen anytime soon.